issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would
by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged
or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In
year, the Company has not yet earned income from Excellence Center (New Building) planned to official grand opening in the following year of February 2018) along with the enlarged customer base of the
shareholders, and subscribe Phoenix’s newly issued shares of 180.00 million shares, totaling 314.60 million shares or 55 percent of total enlarged shares of Phoenix. List of shareholders before and after
performance in 2nd quarter and 6-month period, its cost of services amounted to Baht 21.3 million and Baht 45.4 million, a rise of 12.4% and 20.5% whereas its selling & administrative expenses enlarged at
main office sufficient for not suffering from the same impacts and it should be able to support a large amount of critical business functions or a long-lasting emergengy incidents. In addition, the
million and in payment for additional capital of the associate for Baht 1,365 million. • Net cash used in financing activities of Baht 2,379 million resulting from the loan repayment according to the long
additional capital of the associate for Baht 902 million. The company had net cash used in financing activities of Baht 1,594 million resulting from the loan repayment according to the long-term loan
enhance a company’s ability to generate long-term financial returns. Businesses that fail to make sufficient investments in the future can doom themselves to irrelevance. These businesses need us—their